Category: Q4Syndicate content

GE Healthcare's Q4 profits slide on flat sales growth

January 23, 2015 by Brad Perriello

Profits for General Electric's GE Healthcare business were down 4% on flat sales during the 4th quarter.

GE Healthcare's Q4 profits slide on flat sales growth

Intuitive Surgical dips after hours on Q4 results

January 22, 2015 by Brad Perriello

Intuitive Surgical shares dip in after-hours trading as investors react to 4th-quarter results showing rising expenses, sliding profits and poor year-on-year comps.

Intuitive Surgical dips after hours on Q4 results

Covidien's Q1 earnings top estimates

January 22, 2015 by Brad Perriello

Covidien issues its final quarterly report as a standalone company, saying its fiscal 1st-quarter earnings beat expectations and it prepares for a $43 billion acquisition by Medtronic next week.

Covidien's Q1 earnings top estimates

J&J's medical device sales take a hit

January 20, 2015 by Brad Perriello

Sales for Johnson & Johnson's medical device business slide as the strong dollar takes its toll.

J&J's medical device sales take a hit

Strong dollar hits Stryker's 2015 outlook

January 14, 2015 by MassDevice

Stryker lowers its outlook for 2015, saying the strong dollar will have a larger effect on earnings than previously thought.

Strong dollar hits Stryker's 2015 outlook

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

HeartWare beats on Q4 prelims, launches thoracotomy trial

January 13, 2015 by Brad Perriello

HeartWare International's preliminary sales numbers for the 4th quarter beat expectations as it launches a thoracotomy trial for its implantable heart pump.

HeartWare beats on Q4 prelims, launches thoracotomy trial

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Biomet's Q2 profits surge on lower legal costs

January 6, 2015 by Brad Perriello

Biomet reports surging profits during its fiscal 2nd quarter, citing a nearly $70 million decrease in legal costs compared with the same period last year.

Biomet's Q2 profits surge on lower legal costs

Biomet reported surging 2nd-quarter profits today, saying a 61% reduction in legal costs drove the increase.